My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Tsefalen 50 mg/ml Powder for Oral Suspension for Dogs up to 20 kg and Cats



Nextmune Italy S.r.l.VPA23440/001/003

Main Information

Trade NameTsefalen 50 mg/ml Powder for Oral Suspension for Dogs up to 20 kg and Cats
Active SubstancesCefalexin
Dosage FormPowder for oral suspension
Licence HolderNextmune Italy S.r.l.
License Holder AddressVia Gian Battista Benzoni 50
Palazzo Pignano
CR
26020
Italy
Licence NumberVPA23440/001/003

Group Information

ATC CodeQJ01DB01 cefalexin
Therapeutic ClassAntibacterial
SpeciesCats
Dogs

Status

License statusAuthorised
Licence Issued04/12/2020
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *No document available
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back
Follow medicine

Print